Sentence examples for mild toxicity of from inspiring English sources

Some degree of mild toxicity of FluoroGold and NAC was evident, suggesting that caution must be exercised when relying on FluoroGold as a neuron-counting tool and when designing experiments with long-term delivery of NAC such as clinical trials on patients with chronic disorders.

The monitoring of animal survival and weight confirmed the mild toxicity of injected activities ranging from 11.1 to 22.2 MBq with no weight loss above 10% and no mortality during the follow-up period.

The low efficiency of genetic transposition is a major obstacle preventing the broad clinical application of this method; however, the low cost, convenient manufacturing, and mild toxicity of this system render it attractive as an alternative treatment strategy (Kebriaei et al., 2016).

The results obtained contribute to the knowledge of the chemical composition of mushrooms belonging to the Agaricus genus, and provide some explanation for the reported mild toxicity of A. placomyces and A. pseudopratensis, a phenonomenon that can be explained by a high phenol content, similar to that found in other Xanthodermatei species.

The use of chemotherapy in CRPC therefore remains a subject of active clinical investigation, and the mild toxicity of D makes it an attractive treatment option for the development of combination regimens.

In contrast to the trial conducted by the CALGB, Nakano et al,reported definite activity with only mild toxicity of this combination regimen and concluded that it warrants further clinical evaluation.

Linezolid is in U.S. pregnancy category C, meaning there have been no adequate studies of its safety when used by pregnant women, and although animal studies have shown mild toxicity to the fetus, the benefits of using the drug may outweigh its risks.

Although further clinical study of these agents is required, the downstream location of mTOR in relation to activated receptor tyrosine kinases, plus the relatively mild toxicity profile of these agents, makes them attractive clinical candidates for the treatment of patients with MBC.

The activity and mild toxicity profile of single-agent gemcitabine therapy in untreated (chemonaive) patients with non-small-cell lung cancer (NSCLC) is well documented.

In cases of mild toxicity, lithium discontinuation may suffice.

Epidermal growth factor receptor-targeting agents, with their encouraging efficacy, mild toxicity profile and quality of life benefits, offer hope for patients with advanced cancer.